Literature DB >> 26961680

Identification of two novel mutations in the cornea-specific TGFBI gene causing unique phenotypes in patients with corneal dystrophies.

Sabine Foja1, Katrin Hoffmann2, Claudia Auw-Haedrich3, Thomas Reinhard3, Andreas Rupprecht4,5, Claudia Gruenauer-Kloevekorn4,5.   

Abstract

The purpose of this study was to report on two novel missense mutations of the cornea-specific TGFBI gene in one single patient and in two generations of a family diagnosed with unique corneal dystrophy (CD) phenotypes. Ophthalmologic examination, in several cases ocular coherence tomography of the anterior segment (AS-OCT), was performed in 21 affected patients and in two unaffected members of one affected family. Coding regions of the TGFBI gene were direct sequenced in all 23 individuals. The two novel mutations were verified by RFLP analysis. A novel mutation c.1640T > G (p.Phe574Cys) in exon 12 of the TGFBI gene was detected in one single patient with recurrent granular intrastromal deposits comparable to a type of granular dystrophy. In AS-OCT, the deposit pattern reached up to the Descemet's layer. A further novel mutation c.393G > T(p.Glu131Asp) in exon 4 of the TGFBI gene was detected in all three affected members of one family with superficial cloud- and honeycomb-like opacifications, comparable to a Schnyder corneal dystrophy. Two unaffected members did not carry this alteration. The two identified novel mutations add other two phenotypes in patients suffering from TGFBI-linked CD to those reported so far. In one case, clinical finding indicates a Schnyder corneal dystrophy-like phenotype due to its superficial crystalline shape, and in the second one, granular deposits who reach Descemet's layer indicate a granular CD subtype. Molecular genetic analysis may help to distinguish those subtypes and to decide for specific treatment in time of a wide variation of corneal surgical techniques.

Entities:  

Keywords:  Epithelial corneal dystrophy; Novel mutations; TGFBI gene

Mesh:

Substances:

Year:  2016        PMID: 26961680     DOI: 10.1007/s10792-016-0216-5

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  24 in total

1.  Clinical and immunopathological corneal phenotype in homozygotes for the BIGH3 R124H mutation.

Authors:  C J M Diaper; D F Schorderet; P Chaubert; F L Munier
Journal:  Eye (Lond)       Date:  2005-01       Impact factor: 3.775

2.  TGFBI-promoted adhesion, migration and invasion of human renal cell carcinoma depends on inactivation of von Hippel-Lindau tumor suppressor.

Authors:  Donghao Shang; Yuting Liu; Peiqian Yang; Yongqian Chen; Ye Tian
Journal:  Urology       Date:  2012-02-15       Impact factor: 2.649

3.  Inhibition of TGFBIp expression by lithium: implications for TGFBI-linked corneal dystrophy therapy.

Authors:  Seung-Il Choi; Bong-Yoon Kim; Shorafidinkhuja Dadakhujaev; James V Jester; Hyunmi Ryu; Tae-Im Kim; Eung Kweon Kim
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-05-17       Impact factor: 4.799

4.  New mode of treatment for lattice corneal dystrophy type I: corneal epithelial debridement and fibronectin eye drops.

Authors:  Yukiko Morita; Tai-Ichiro Chikama; Naoyuki Yamada; Naoyuki Morishige; Koh-Hei Sonoda; Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2011-11-12       Impact factor: 2.447

5.  Survey of patients with granular, lattice, avellino, and Reis-Bücklers corneal dystrophies for mutations in the BIGH3 and gelsolin genes.

Authors:  N A Afshari; J E Mullally; M A Afshari; R F Steinert; A P Adamis; D T Azar; J H Talamo; C H Dohlman; T P Dryja
Journal:  Arch Ophthalmol       Date:  2001-01

6.  A model of FAS1 domain 4 of the corneal protein beta(ig)-h3 gives a clearer view on corneal dystrophies.

Authors:  Naomi J Clout; Erhard Hohenester
Journal:  Mol Vis       Date:  2003-09-11       Impact factor: 2.367

7.  A corneal dystrophy associated with transforming growth factor beta-induced Gly623Asp mutation an amyloidogenic phenotype.

Authors:  Claudia Auw-Haedrich; Hansjürgen Agostini; Ina Clausen; Thomas Reinhard; Philipp Eberwein; Daniel F Schorderet; Claudia Gruenauer-Kloevekorn
Journal:  Ophthalmology       Date:  2008-11-18       Impact factor: 12.079

8.  BIGH3 (TGFBI) Arg124 mutations influence the amyloid conversion of related peptides in vitro.

Authors:  Clair-Florent Schmitt-Bernard; Alain Chavanieu; Gudrun Herrada; Guy Subra; Bernard Arnaud; Jacques G Demaille; Bernard Calas; Angel Argilés
Journal:  Eur J Biochem       Date:  2002-11

9.  Expression, purification and characterization of fourth FAS1 domain of TGFβIp-associated corneal dystrophic mutants.

Authors:  Murugan Elavazhagan; Rajamani Lakshminarayanan; Lei Zhou; Lim Wei Ting; Louis Tong; Roger W Beuerman; Shyam S Chaurasia; Jodhbir S Mehta
Journal:  Protein Expr Purif       Date:  2012-05-02       Impact factor: 1.650

10.  Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits.

Authors:  Henrik Karring; Ebbe Toftgaard Poulsen; Kasper Runager; Ida B Thøgersen; Gordon K Klintworth; Peter Højrup; Jan J Enghild
Journal:  Mol Vis       Date:  2013-04-12       Impact factor: 2.367

View more
  2 in total

1.  A pathogenic variant in the transforming growth factor beta I (TGFBI) in four Iranian extended families segregating granular corneal dystrophy type II: A literature review.

Authors:  Aliasgar Mohammadi; Azam Ahmadi Shadmehri; Mahnaz Taghavi; Gholamhossein Yaghoobi; Mohammad Reza Pourreza; Mohammad Amin Tabatabaiefar
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

2.  TGF-β1 enhanced myocardial differentiation through inhibition of the Wnt/β-catenin pathway with rat BMSCs.

Authors:  Yang Lv; Xiu-Juan Li; Hai-Ping Wang; Bo Liu; Wei Chen; Lei Zhang
Journal:  Iran J Basic Med Sci       Date:  2020-08       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.